Outcome of the AGM of the company

Welcure Drugs & Pharmaceuticals held its 33rd AGM on September 27, 2025, via video conferencing, where all 14 resolutions were passed with the required majority. Routine items included approval of audited financial statements for FY ending March 31, 2025, appointment of a director liable to retire by rotation, and appointment of statutory and secretarial auditors. Several significant corporate actions were also approved, including a sub-division/split of equity shares, a bonus issue of equity shares, and an increase in authorised share capital. Members also approved raising funds up to Rs. 80 crores through a Qualified Institutions Placement (QIP) and raising the FPI/FII shareholding limit to 49% of paid-up equity capital. Additionally, the threshold for loans, guarantees, and investments under Section 186 was increased.